Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1134024.RAblCC_WfQ1uVFbxykuG3y8gfPovpjxPg5QN4zWpAq3e4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1134024.RAblCC_WfQ1uVFbxykuG3y8gfPovpjxPg5QN4zWpAq3e4130_assertion type Assertion NP1134024.RAblCC_WfQ1uVFbxykuG3y8gfPovpjxPg5QN4zWpAq3e4130_head.
- NP1134024.RAblCC_WfQ1uVFbxykuG3y8gfPovpjxPg5QN4zWpAq3e4130_assertion description "[Taken together, our data suggest that the anti-VEGFR-1 DNAzyme may be used as a therapeutic agent for the treatment of cancer, such as NPC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1134024.RAblCC_WfQ1uVFbxykuG3y8gfPovpjxPg5QN4zWpAq3e4130_provenance.
- NP1134024.RAblCC_WfQ1uVFbxykuG3y8gfPovpjxPg5QN4zWpAq3e4130_assertion evidence source_evidence_literature NP1134024.RAblCC_WfQ1uVFbxykuG3y8gfPovpjxPg5QN4zWpAq3e4130_provenance.
- NP1134024.RAblCC_WfQ1uVFbxykuG3y8gfPovpjxPg5QN4zWpAq3e4130_assertion SIO_000772 24306423 NP1134024.RAblCC_WfQ1uVFbxykuG3y8gfPovpjxPg5QN4zWpAq3e4130_provenance.
- NP1134024.RAblCC_WfQ1uVFbxykuG3y8gfPovpjxPg5QN4zWpAq3e4130_assertion wasDerivedFrom befree-2016 NP1134024.RAblCC_WfQ1uVFbxykuG3y8gfPovpjxPg5QN4zWpAq3e4130_provenance.
- NP1134024.RAblCC_WfQ1uVFbxykuG3y8gfPovpjxPg5QN4zWpAq3e4130_assertion wasGeneratedBy ECO_0000203 NP1134024.RAblCC_WfQ1uVFbxykuG3y8gfPovpjxPg5QN4zWpAq3e4130_provenance.